Filing Flows › C4 Therapeutics (CCCC) › Recalls, complaints & regulation
C4 Therapeutics (CCCC): clinical trials
C4 Therapeutics (CCCC) beyond its filings: 3 active clinical trials.
C4 Therapeutics' latest quarter
C4 Therapeutics, Q3 2026: revenue $8.5M (-25% year over year), operating margin -290.5%, net loss $21.8M, operating cash flow −$26.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does C4 Therapeutics have?
3 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.